{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:23:36Z","timestamp":1790900616678,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000837","name":"University of Nottingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.semarthrit.2020.09.021","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T17:38:02Z","timestamp":1610041082000},"page":"650-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group"],"prefix":"10.1016","volume":"51","author":[{"given":"Amy","family":"Fuller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Diaz-Torne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Filippou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Pascart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Hensey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grossberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder A.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semarthrit.2020.09.021_bib0001","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.2010.139105","article-title":"European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.09.021_bib0002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/BOR.0000000000000246","article-title":"Calcium pyrophosphate deposition disease: a review of epidemiologic findings","volume":"28","author":"Abhishek","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.09.021_bib0003","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.40517","article-title":"Review: unmet needs and the path forward in joint disease associated with calcium pyrophosphate crystal deposition","volume":"70","author":"Abhishek","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.09.021_bib0004","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13075-014-0458-4","article-title":"Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial","volume":"16","author":"Finckh","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.09.021_bib0005","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3899\/jrheum.181097","article-title":"Core domain set selection according to OMERACT filter 2.1: the OMERACT methodology","volume":"46","author":"Maxwell","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.09.021_bib0006","unstructured":"Boers, M., et\u00a0al. OMERACT handbook chapter 4: developing core domain sets. Available from: https:\/\/omeracthandbook.org\/handbook (Accessed online 23 June 2020)."},{"issue":"7","key":"10.1016\/j.semarthrit.2020.09.021_bib0007","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","article-title":"Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0","volume":"67","author":"Boers","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.09.021_bib0008","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.semarthrit.2020.05.015","article-title":"Outcome domains reported in calcium pyrophosphate deposition studies: a scoping review by the OMERACT CPPD working group","volume":"50","author":"Cai","year":"2020","journal-title":"Seminars Arthritis Rheumatism"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.09.021_bib0009","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1499-4046(06)60097-3","article-title":"Content analysis: review of methods and their applications in nutrition education","volume":"34","author":"Kondracki","year":"2002","journal-title":"J Nutr Educ Behav"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.09.021_bib0010","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3899\/jrheum.181096","article-title":"OMERACT filter 2.1: elaboration of the conceptual framework for outcome measurement in health intervention studies","volume":"46","author":"Boers","year":"2019","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.09.021_bib0011","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3899\/jrheum.180353","article-title":"Perceptions of patients, caregivers, and healthcare providers of idiopathic inflammatory myopathies: an international OMERACT study","volume":"46","author":"Mecoli","year":"2019","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.09.021_bib0012","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3899\/jrheum.131252","article-title":"Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop","volume":"41","author":"Bykerk","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.09.021_bib0013","first-page":"86","article-title":"World health organization and international league of associations for rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials","volume":"41","author":"Boers","year":"1994","journal-title":"J Rheumatol Suppl"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.09.021_bib0014","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.09.021_bib0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3899\/jrheum.131246","article-title":"OMERACT endorsement of measures of outcome for studies of acute gout","volume":"41","author":"Singh","year":"2014","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.09.021_bib0016","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3899\/jrheum.181194","article-title":"The OMERACT-OARSI core domain set for measurement in clinical trials of hip and\/or knee osteoarthritis","volume":"46","author":"Smith","year":"2019","journal-title":"J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220303188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220303188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:07:28Z","timestamp":1758733648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220303188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0049017220303188"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.09.021","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}